These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 313711)

  • 21. Electroretinogram in cone dystrophy.
    Iijima H; Yamaguchi S; Kogure S; Hosaka O; Shibutani T
    Jpn J Ophthalmol; 1991; 35(4):453-66. PubMed ID: 1821435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
    Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
    Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phenotype of early-onset retinal degeneration in persons with RDH12 mutations.
    Schuster A; Janecke AR; Wilke R; Schmid E; Thompson DA; Utermann G; Wissinger B; Zrenner E; Gal A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1824-31. PubMed ID: 17389517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bio-electric tests in tapeto-retinal peripheral degeneration].
    François J; De Rouck A
    Bull Soc Belge Ophtalmol; 1974; 166(2):504-16. PubMed ID: 4433950
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of a family with cone degeneration].
    Malbrel PH; Hache JC; Malbrel C
    Bull Soc Ophtalmol Fr; 1976; 76(7-8):747-51. PubMed ID: 1088506
    [No Abstract]   [Full Text] [Related]  

  • 27. High-resolution retinal imaging of cone-rod dystrophy.
    Wolfing JI; Chung M; Carroll J; Roorda A; Williams DR
    Ophthalmology; 2006 Jun; 113(6):1019.e1. PubMed ID: 16650474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
    Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
    Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuro-ophthalmic presentation of cone dysfunction syndromes in the adult.
    Zervas JP; Smith JL
    J Clin Neuroophthalmol; 1987 Dec; 7(4):202-18. PubMed ID: 2963026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive generalized cone dysfunction.
    François J; de Rouck A; Verriest G; de Laey JJ; Cambie E
    Ophthalmologica; 1974; 169(4):255-84. PubMed ID: 4547582
    [No Abstract]   [Full Text] [Related]  

  • 31. [Congenital achromatopsia].
    Pinckers A
    Ann Ocul (Paris); 1972 Jul; 205(7):821-34. PubMed ID: 4539461
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of novel RPGR ORF15 mutations in X-linked progressive cone-rod dystrophy (XLCORD) families.
    Ebenezer ND; Michaelides M; Jenkins SA; Audo I; Webster AR; Cheetham ME; Stockman A; Maher ER; Ainsworth JR; Yates JR; Bradshaw K; Holder GE; Moore AT; Hardcastle AJ
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1891-8. PubMed ID: 15914600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alström syndrome. Report of 22 cases and literature review.
    Russell-Eggitt IM; Clayton PT; Coffey R; Kriss A; Taylor DS; Taylor JF
    Ophthalmology; 1998 Jul; 105(7):1274-80. PubMed ID: 9663233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundus flavimaculatus and dystrophy of the cones].
    Malbrel C; Foltz A; Alame M; Talmud M
    Bull Soc Ophtalmol Fr; 1979; 79(11-12):1099-102. PubMed ID: 317901
    [No Abstract]   [Full Text] [Related]  

  • 35. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
    Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
    Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cone dystrophies and dysfunctions].
    Zol'nikova IV; Shamshinova AM
    Vestn Oftalmol; 2001; 117(4):48-52. PubMed ID: 11569187
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical features and a follow-up study in a family with X-linked progressive cone-rod dystrophy.
    Mäntyjärvi M; Nurmenniemi P; Partanen J; Myöhänen T; Peippo M; Alitalo T
    Acta Ophthalmol Scand; 2001 Aug; 79(4):359-65. PubMed ID: 11453854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant cone dystrophy caused by a novel mutation in the GCAP1 gene (GUCA1A).
    Jiang L; Katz BJ; Yang Z; Zhao Y; Faulkner N; Hu J; Baird J; Baehr W; Creel DJ; Zhang K
    Mol Vis; 2005 Feb; 11():143-51. PubMed ID: 15735604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive human cone-rod dysfunction (dystrophy).
    Fishman GA
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(4 Pt 1):OP716-24. PubMed ID: 1085512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratoconus associated with cone-rod dystrophy: a case report.
    Fogla R; Iyer GK
    Cornea; 2002 Apr; 21(3):331-2. PubMed ID: 11917188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.